Simvastatin improves diabetes-induced coronary endothelial dysfunction

Keyphrases

• 3-hydroxy-3-methylglutaryl-CoA Reductase 10%
• Acetylcholine 50%
• Apocynin 10%
• Arginine 30%
• Cardiovascular Morbidity 10%
• Coronary Artery 30%
• Coronary Artery Endothelial Cells 30%
• Coronary Dysfunction 10%
• Coronary Endothelial Dysfunction 100%
• Coronary Vessels 30%
• Diabetes 100%
• Diabetic 10%
• Diabetic Patients 10%
• Diabetic Rats 40%
• Dichlorofluorescein 20%
• Endothelial Nitric Oxide Synthase (eNOS) 10%
• High Glucose 30%
• Hydrochloride 10%
• L-NAME 20%
• Mevalonate 10%
• NADPH Oxidase Inhibitor 10%
• NO Bioavailability 20%
• Oxidative Stress 30%
• Protein Level 10%
• Rat Coronary Arteries 30%
• Reactive Oxygen Species Production 10%
• Reductase Inhibitors 10%
• Simvastatin 100%
• Sodium Nitroprusside 10%
• Superoxide Production 10%
• Transcoronary 10%
• Tyrosine 20%
• Vasorelaxation 10%

Pharmacology, Toxicology and Pharmaceutical Science

• 3 Nitrotyrosine 20%
• Acetylcholine 50%
• Apocynin 10%
• Arginine 30%
• Arginine Methyl Ester 10%
• Bioavailability 20%
• Chloride 10%
• Diabetes Mellitus 40%
• Dichlorofluorescein 20%
• Endothelial Dysfunction 100%
• Mevalonic Acid 10%
• Nitroprusside Sodium 10%
• Oxidoreductase 10%
• Oxidoreductase Inhibitor 10%
• Reactive Oxygen Metabolite 10%
• Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase 10%
• Simvastatin 100%
• Superoxide 10%
• Synthetase 10%